SEARCH

SEARCH BY CITATION

References

  • 1
    Whitaker BI, Green J, King MR, Leibeg LL, Sclumpf KS, Schreiber GB: Nationwide Blood Collection and Utilization Survey Report. in. Washington, DC, Department of Health and Human Services, 2008.
  • 2
    Murphy S: Platelets from pooled buffy coats: an update. Transfusion 2005; 45:634639
  • 3
    Slichter SJ: Platelet transfusion therapy. Hematol Oncol Clin North Am 2007; 21:697729 vii.
  • 4
    Armstrong B, Hardwick J, Raman L, Smart E, Wilkinson RW: Introduction to blood transfusion technology. ISBT Sci Ser 2008; 3:165167
  • 5
    Zumberg MS, Del Rosario ML, Nejame CF, Pollock BH, Garzarella L, Kao KJ, Lottenberg R, Wingard JR: A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002; 8:569576
  • 6
    Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med 1997; 337:18701875
  • 7
    Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gackle R, Geer T, Harms P, Loffler B, Ohl S, Otremba B, Raab M, Schonrock-Nabulsi P, Strobel G, Winter R, Link H: Safety and cost effectiveness of a 10 × 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998; 91:36013606
  • 8
    Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP: Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 1997; 15:11431149
  • 9
    Gil-Fernandez JJ, Alegre A, Fernandez-Villalta MJ, Pinilla I, Gomez GV, Martinez C, Tomas JF, Arranz R, Figuera A, Camara R, Fernandez-Ranada JM: Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996; 18:931935
  • 10
    Lawrence JB, Yomtovian RA, Hammons T, Masarik SR, Chongkolwatana V, Creger RJ, Manka A, Lazarus HM: Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001; 41:6776
  • 11
    Navarro JT, Hernandez JA, Ribera JM, Sancho JM, Oriol A, Pujol M, Milla F, Feliu E: Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica 1998; 83:9981000
  • 12
    Sagmeister M, Oec L, Gmur J: A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood 1999; 93:31243126
  • 13
    Gmur J, Burger J, Schanz U, Fehr J, Schaffner A: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338:12231226
  • 14
    Höchsmann B, Seidel H, Wiesneth M, Schrezenmeier H: Is the low platelet transfusion trigger in the new cross-sectional German guidelines of risk in outpatient setting? Prophylactic platelet transfusions in aplastic anemia. Transfus Med Hemother 36 (suppl 1): 2010, p. 38.
  • 15
    Kim H, Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Kim WK, Lee JS, Lee KH: Risk score model for fatal intracranial hemorrhage in acute leukemia. Leukemia 2006; 20:770776
  • 16
    Webert K, Cook RJ, Sigouin CS, Rebulla P, Heddle NM: The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica 2006; 91:15301537
  • 17
    German Association of Physicians: Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives. Transfus Med Hemother 2009; 36:347481
  • 18
    Cid J, Nascimento JD, Vicent A, Aguinaco R, Escoda L, Ugarriza A, Llorente A: Evaluation of low platelet counts by optical, impedance, and CD61-immunoplatelet methods: estimation of possible inappropriate platelet transfusion. Transfusion 2010; 50:795800.
  • 19
    Segal HC, Briggs C, Kunka S, Casbard A, Harrison P, Machin SJ, Murphy MF: Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. Br J Haematol 2005; 128:520525
  • 20
    Briggs C, Harrison P, Machin SJ: Continuing developments with the automated platelet count. Int J Lab Hematol 2007; 29:7791
  • 21
    Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S: Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002; 16:3445
  • 22
    Wandt H, Schaefer-Eckart K, Frank M, Birkmann J, Wilhelm M: A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37:387392
  • 23
    Wandt H, Schaefer-Eckart K, Wendelin K, Thalheimer M, Schwerdtfeger R, Conradi R, Kaufmann M, Leimer L, Dölken G, Klenner AF, Schaich M, Ehninger G: A therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and reduces platelet transfusion numbers significantly: Analysis of a randomized study after autologous stem cell transplantation. Onkologie 2009; 32 (suppl 4):87
  • 24
    Wandt H, Schaefer-Eckart K, Pilz B, Thalheimer M, Ho AD, Schaich M, Kaufmann M, Aulitzky WE, Haenel M, Herbst R, Dolken G, Klenner AF, Freund M, Junghans C, Ehninger G: Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients. Blood 2009; 114:20
  • 25
    Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M, Rebulla P: A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006; 46:903911
  • 26
    Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, Ackerman SJ, Bleecker GC, Mangan KF: Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999; 39:674681
  • 27
    Norol F, Bierling P, Roudot-Thoraval F, Le Coeur FF, Rieux C, Lavaux A, Kuentz M, Duedari N: Platelet transfusion: a dose-response study. Blood 1998; 92:14481453
  • 28
    Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S: Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood 2001; 98:13461351
  • 29
    Tinmouth A, Tannock IF, Crump M, Tomlinson G, Brandwein J, Minden M, Sutton D: Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004; 44:17111719
  • 30
    Sensebe L, Giraudeau B, Bardiaux L, Deconinck E, Schmidt A, Bidet ML, Leniger C, Hardy E, Babault C, Senecal D: The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood 2005; 105:862864
  • 31
    Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Brandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee KA: A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009; 113:15641573
  • 32
    Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S: Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362:600613
  • 33
    Schrezenmeier H, Seifried E: Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 2010; epub ahead of print.
  • 34
    Bundesärztekammer: Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Köln, Deutscher Ärzteverlag, 2009.
  • 35
    Heddle NM, Arnold DM, Boye D, Webert KE, Resz I, Dumont LJ: Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion 2008; 48:14471458
  • 36
    Heal JM, Rowe JM, McMican A, Masel D, Finke C, Blumberg N: The role of ABO matching in platelet transfusion. Eur J Haematol 1993; 50:110117
  • 37
    Lee EJ, Schiffer CA: ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial. Transfusion 1989; 29:384389
  • 38
    Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R: Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105:41064114
  • 39
    Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW: Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990; 75:408413
  • 40
    Heal JM, Rowe JM, Blumberg N: ABO and platelet transfusion revisited. Ann Hematol 1993; 66:309314
  • 41
    Blumberg N, Heal JM: ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery. Transfusion 2002; 42:15271528
  • 42
    Lin Y, Callum JL, Coovadia AS, Murphy PM: Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients. Transfusion 2002; 42:166172
  • 43
    Lozano M, Cid J: The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003; 17:5768
  • 44
    Bartley AN, Carpenter JB, Berg MP: D+ platelet transfusions in D- patients: cause for concern? Immunohematology 2009; 25:58
  • 45
    Hod E, Schwartz J: Platelet transfusion refractoriness. Br J Haematol 2008; 142:348360
  • 46
    Tinmouth AT, Semple E, Shehata N, Branch DR: Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium. Transfus Med Rev 2006; 20:294314
  • 47
    O’Connell B, Lee EJ, Schiffer CA: The value of 10-minute posttransfusion platelet counts. Transfusion 1988; 28:6667
  • 48
    Dzik S: How I do it: platelet support for refractory patients. Transfusion 2007; 47:374378
  • 49
    Laundy GJ, Bradley BA, Rees BM, Younie M, Hows JM: Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia. Transfusion 2004; 44:814825
  • 50
    Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337:186118690
  • 51
    Fontao-Wendel R, Silva LC, Saviolo CB, Primavera B, Wendel S: Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang 2007; 93:241249
  • 52
    Kiefel V, Konig C, Kroll H, Santoso S: Platelet alloantibodies in transfused patients. Transfusion 2001; 41:766770
  • 53
    Moroff G, Garratty G, Heal JM, MacPherson BR, Stroncek D, Huang ST, Ho W, Petz LD, Leach MF, Lennon SS: Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992; 32:633640
  • 54
    Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM: Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000; 40:14461456
  • 55
    Rebulla P, Morelati F, Revelli N, Villa MA, Paccapelo C, Nocco A, Greppi N, Marconi M, Cortelezzi A, Fracchiolla N, Martinelli G, Deliliers GL: Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. Br J Haematol 2004; 125:8389
  • 56
    Sacher RA, Kickler TS, Schiffer CA, Sherman LA, Bracey AW, Shulman IA: Management of patients refractory to platelet transfusion. Arch Pathol Lab Med 2003; 127:409414
  • 57
    Kickler TS, Braine H, Ness PM: The predictive value of crossmatching platelet transfusion for alloimmunized patients. Transfusion 1985; 25:385389